Princeton, NJ May 15, 2012 – CoreLab Partners, Inc, a leading independent core lab providing centralized cardiac safety services and medical imaging assessment, is set to attend and actively participate in several upcoming industry events around the world over the next several months.
“As we continue to build our global brand, our industry experts and acknowledged key opinion leaders are slated to attend and present at several upcoming tradeshows and industry conferences around the globe” said CoreLab Partners’ Senior Vice President of Global Clinical Operations, Kevin Duffy. “Our commitment to science-driven results has established CoreLab Partners as the premier core lab in the sector and has distinguished our services with a growing list of sponsor partners in all regions of the world”, added Duffy.
CoreLab Partners invites you to learn more about their full line of cardiac safety and imaging science capabilities at these important industry events:
23-24 May 2012
Exploratory Clinical Development World
Exhibiting: Booth # 32
Jeffrey Heilbraun, MS, Director, Strategic Business Development, presenting, "Should a cardiac safety assessment strategy start with the first in human study?"
Thursday, 24 May, 14:00
28-29 May 2012
3rd DIA Cardiac Safety Workshop in Japan
Tower Hall Funabori, Tokyo, Japan
Program Chair: Boaz Mendzelevski, MD, Vice President, Cardiology, CoreLab Partners Inc.
Boaz Mendzelevski, MD, Vice President, Cardiology, CoreLab Partners Inc, sessions chair:
“Cardio-Oncology: Avoiding Oncology Drug Cardiotoxicity”, Tuesday, 29 May 2012, 10:45 am
“Cardio-Metabolic: Assessing CV Safety of Diabetes Drugs”, Tuesday, 29 May 2012, 1:40 pm
DIA CS Japan
2-4 June 2012
American Society of Clinical Oncology (ASCO)
Exhibiting: Booth # 23075
25-27 June 2012
DIA 2012 Annual DIA Meeting
Exhibiting: Booth # 2625
About CoreLab Partners, Inc
CoreLab Partners, with offices in North America, Europe and Asia, provides comprehensive medical image assessment and cardiac safety services to the pharmaceutical, biotechnology and medical device industries. An efficient operational process facilitates successful new drug development programs by employing an experienced clinical operations team combined with board certified, sub-specialty trained Radiologists, Cardiologists, nuclear medicine physicians and Oncologists. CoreLab Partners delivers disciplined solutions for the collection, analysis and management of patient images and cardiac safety & efficacy information during drug development. Driven by best-in-class science, emerging technologies and service quality, CoreLabs’ is a global leader providing imaging sciences in all major modalities complemented by service offerings in the conduct of automated ECG, Thorough QT, Holter Monitoring, Ambulatory Blood Pressure Monitoring and Pulse Wave Analysis